Kapitel 75: We agreed
"Oh, husband, then you must pay attention to safety when you go out," Lin Yuanyuan said.
Lin Yuanyuan had been taking care of the baby at home, and she only went to the company once or twice. However, she knew that her husband had several companies, and his business must have been busy, so business trips and the like were inevitable.
"Okay, it shouldn't be too long this time," Ye Cheng replied.
After the two talked for a while, Ye Cheng hung up the phone. After more than an hour, Ye Cheng brought the group to the airport.
This time, Ye Cheng not only brought Fei Wei, a full-time bodyguard, but also related professionals from the investment company, such as accountants, lawyers, and actuaries. After all, this time it is a stake in Xinhe Pharmaceutical, which will decide the life and death of a pharmaceutical company. The action is not small—at least a transaction worth hundreds of millions.
A few hours later, Ye Cheng and his party arrived in Wushi and checked into a hotel.
The next step is to investigate the detailed information of Xinhe Pharmaceutical and then contact the senior management of Xinhe Pharmaceutical.
Nangong Xiang, the chairman of Xinhe Pharmaceutical, stood in front of the floor-to-ceiling glass window of the office, looking at the factory building not far away, his face full of loneliness.
No one would have imagined that a once-vibrant innovative drug company would end in a few short years and come to an end.
He put a lot of effort into this pharmaceutical company, a small state-owned enterprise pharmaceutical factory. After the restructuring and reorganization, it was rejuvenated, and he set the direction and strategy of innovative drugs.
It had been smooth sailing all the time until the listing was successful.
He also achieved fame and was worth a billion dollars.
However, with the failure of several innovative drug research and development projects and the consumption of too much capital, coupled with the increasingly fierce external competition, the market was dominated by some leading players, and the company's survival became more and more difficult.
In this way, under the debt crisis, the capital chain was broken, and the company could no longer support itself. Even the introduction of external capital was futile because of the continuous failures, and no one in the capital circle was optimistic about the development prospects of Xinhe Pharmaceutical.
Now the company has entered the stage of liquidation and bankruptcy.
Unless, at this time, a large investment could be attracted, the debts repaid, and the reorganization completed, Xinhe Pharmaceutical Company could be reborn.
"But this is almost impossible.
Because the funds needed are at least several hundred million.
A lot of capital is available.
Credible pharmaceutical companies have no hope of making profits.
Who would be foolish enough to invest hundreds of millions? This is completely worthless.
Even if it is a waste of water, you can still see some waves, and with this investment of several hundred million, it is estimated that the shadow is not seen, and ultimately bankruptcy cannot be avoided.
After all, the research and development of innovative drugs by pharmaceutical companies is really too expensive.
Nangong Xiang took a deep breath and made several more calls, but no one answered.
Because the person on the other side didn't want to answer his call at all.
"Is there no hope?"
Nangong Xiang muttered to himself.
At this moment, an assistant rushed in in a hurry and said with great excitement, "Chairman, good news! An investment company has come to Wu City and wants to inspect our Xinhe Pharmaceutical."
"What?"
Nangong Xiang was shocked and quickly asked, "Do you know what investment company it is?"
"It's called Chenyuan Investment, and it came from Pengcheng," said the assistant.
"Chenyuan Investment?"
Nangong Xiang showed a hint of doubt because he knew a lot about well-known investment companies in China, and there was no such investment company at all.
"You check the background of this Chenyuan investment," Nangong Xiang said.
"Chairman, I checked it right away. It was only established last year. It has very little investment experience, but it has a big bright spot. This company invested in the previously popular movie Dragon Group 1 and got 200%. The most successful one is the investment in the Heizhou cobalt ore project, which was purchased from Heishan Special Materials for 50 million yuan, and then a few months later, the income was as high as dozens of times," said the assistant.
"Oh, so great!" Nangong Xiang was extremely surprised.
Although the name is not famous, it is very unusual just from the perspective of investment projects.
What's more, now that their own company is at stake, there is nothing to be picky about.
As long as the other party has the strength to invest, he will accept it 100%.
After all, after accepting the investment, there is still a silver lining. Otherwise, the only way to go is to liquidate and go bankrupt.
This is his hard work, and he will not give up until the last moment.
"Okay, promise them, send... Forget it; I'll pick them up in person." 1
Nangong Xiang said.
Two hours later, Ye Cheng and his party entered Xinhe Pharmaceutical.
"Mr. Ye, you are welcome to visit our company.
Nangong Xiang brought the company executives to greet him.
Specifications are very high.
Every high-level person has infinite expectations.
If you go bankrupt, don't say one: all; at least the loss will be very large.
"Chairman Nangong, it is a great pleasure to meet you. I hope our sudden arrival will not disturb your company.
Ye Cheng smiled and shook hands with Nangong Xiang.
Long before he came, he had already investigated the detailed information of Xinhe Pharmaceutical, and he knew all about Nangong Xiang and several other high-level executives.
"How could it be? We are waiting for you, Mr. Ye.
Nangong Xiang laughed.
Under the guidance of Nangong Xiang, the group entered the office building and sat down in a spacious conference room.
After the two sides were polite, they quickly entered the topic.
Nangong Xiang felt that he had briefly described the company's situation.
"Mr. Ye, our company is indeed very difficult. If there is no external capital injection, liquidation and bankruptcy are inevitable.
Nangong Xiang said it with a sigh.
This is a clear sign.
He didn't even have the right to bargain.
If the news of liquidation and bankruptcy does not come out, he can still negotiate.
But now he had to keep Ye Cheng.
This is the only way to make a life-saving investment.
Ye Cheng looked at Xinhe Pharmaceutical's data reports and other information, such as debt ratios, losses, etc.
He can only take a rough look, but this time he brought a professional team here, and these people have participated in many mergers and acquisitions.
"Mr. Ye, this is some data that we have calculated and analyzed."
After some silence, an actuary next to him handed a note to Ye Cheng.
Ye Cheng took a look, and then he knew what he knew and said to Nangong Xiang, "Chairman Nangong, I can invest 380 million, but I have to get 35% of the equity. Of course, I will not interfere in the company's business management, only dividends."
When Nangong Xiang heard this, he fell silent.
Because this requirement is too high, the market value of Xinhe Pharmaceutical has shrunk to less than 1.1 billion.
At its peak, Xinhe Pharmaceuticals had a market value of over $10 billion.
Even if it has shrunk sharply in recent years, there is still a scale of two or three billion.
"Mr. Ye, our shareholders need to discuss it," Nangong Xiang said.
"Can?" Ye Cheng nodded.
Soon, Nangong Xiang and other senior officials left the conference room.
About half an hour later, Nangong Xiang and the others came back.
"Mr. Ye, we agreed."
Wöchentlicher Energiestatus
-- Power-
Rangliste 
-- Power-
Stein